Resveratrol treatment ameliorates hepatic damage via the TGF-β/SMAD signaling pathway in a phenobarbital/CCl۴-induced hepatic fibrosis model
Publish place: Iranian Journal of Basic Medical Sciences، Vol: 27، Issue: 9
Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 40
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-27-9_006
تاریخ نمایه سازی: 31 تیر 1403
Abstract:
Objective(s): Liver fibrosis is a wound healing response characterized by excessive accumulation of extracellular matrix proteins. This study aimed to investigate the effects of resveratrol treatment on the TGF-β/SMAD signaling pathway and related biochemical parameters, apoptosis, and liver regeneration phenobarbital-CCl۴ induced hepatic fibrosis rat model. Materials and Methods: This model was created through phenobarbital and CCl۴ (۰.۲–۰.۳۵ ml/kg). Resveratrol (۱ mg/kg/day) was administered to the fibrosis and control groups. Immunohistochemical staining was performed to evaluate αSMA, TGF-β۱, and PCNA in liver tissue. The TUNEL method and Masson’s Trichome staining were used to determine apoptosis and collagen accumulation. AST, ALP, ALT, total protein, and total bilirubin levels were measured to determine biochemical status. SMAD۲, SMAD۳, SMAD۴, and SMAD۷ expression levels were measured to determine TGF-β۱ related hepatic fibrosis. Results: The SMAD۲, SMAD۳, and SMAD۴ mRNA expression levels were increased and the SMAD۷ mRNA expression level was decreased in the fibrosis control group. The SMAD۷ mRNA expression level was higher in the phenobarbital-CCl۴ induced resveratrol treated group. Increased biochemical parameters indicating hepatic damage, increased number of apoptotic cells, and collagen accumulation surrounding the central vein were observed in the fibrosis group compared with the other groups. It was concluded that administration of resveratrol ameliorates the adverse effects of hepatic fibrosis by regulating biochemical parameters, controlling TGF-β۱/SMAD signaling, enhancing tissue regeneration, and reducing apoptosis in liver cells. Conclusion: Resveratrol can be a beneficial option for the prevention of liver damage in a phenobarbital-CCl۴ induced hepatic fibrosis.
Keywords:
Carbon tetrachloride (CCl۴) , Hepatic fibrosis , Liver , Resveratrol , Transforming growth factor β/small mother against decapentaplegic (TGF-β/SMAD) signalling , SMAD Proteins
Authors
Merve Aykaç
Department of Medical Biology, Faculty of Medicine, Ataturk University, Erzurum, Turkey
Eda Balkan
Department of Medical Biology, Faculty of Medicine, Ataturk University, Erzurum, Turkey
Semin Gedi̇kli
Department of Histology and Embrylogy, Faculty of Veterinary, Ataturk University, Erzurum, Turkey
Nurinnisa Öztürk
Department of Medical Biochemistry, Faculty of Medicine, Ataturk University, Erzurum,Turkey
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :